Chinese english Germany Japanese Korea

ANTI-COLLAGEN TYPE II

ANTI-COLLAGEN TYPE II Struktur
CAS-Nr.
Englisch Name:
ANTI-COLLAGEN TYPE II
Synonyma:
ANTI-COLLAGEN II;ANTI-COLLAGEN TYPE II;ANTI-COLLAGEN II HUMAN;ANTI-COLLAGEN TYPE II, HUMAN;ANTI-HUMAN COLLAGEN, TYPE II;ANTI-COLLAGEN, HUMAN, TYPE II;ANTI-COLLAGEN TYPE II, BOVINE;ANTI-COLLAGEN TYPE II, MAMMALIAN;ANTI-COLLAGEN, TYPE II RABBIT PAB;ANTI-COLLAGEN, TYPE II (AB-1), HUMAN
CBNumber:
CB8234182
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file
Request For Quotation

ANTI-COLLAGEN TYPE II Eigenschaften

storage temp. 
−20°C

Sicherheit

ANTI-COLLAGEN TYPE II Chemische Eigenschaften,Einsatz,Produktion Methoden

ANTI-COLLAGEN TYPE II Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ANTI-COLLAGEN TYPE II Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 30)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Sigma-Aldrich 021-61415566 800-8193336
 orderCN@merckgroup.com China 51471 80

()Verwandte Suche:

Bromcyan Oxalsäuredinitril
  • Monoclonal Anti-Collagen, Type II antibody produced in mouse
  • ANTI-COLLAGEN, HUMAN, TYPE II
  • ANTI-COLLAGEN II
  • ANTI-COLLAGEN II HUMAN
  • ANTI-COLLAGEN TYPE II
  • ANTI-COLLAGEN, TYPE II (AB-1), HUMAN
  • ANTI-COLLAGEN, TYPE II (AB-1) MOUSE MAB
  • ANTI-COLLAGEN TYPE II, BOVINE
  • ANTI-COLLAGEN, TYPE II, CYANOGEN BROMIDE FRAGMENTS, MOUSE
  • ANTI-COLLAGEN, TYPE II, CYANOGEN BROMIDE FRAGMENTS, MOUSE CHONDROSARCOMA (RABBIT)
  • ANTI-COLLAGEN, TYPE II, CYANOGEN BROMIDE FRAGMENTS RABBIT PAB
  • ANTI-COLLAGEN, TYPE II, CYANOGEN BROMIDE FRAGMENTS, RAT
  • ANTI-COLLAGEN, TYPE II, CYANOGEN BROMIDE FRAGMENTS, RAT CHONDROSARCOMA (RABBIT)
  • ANTI-COLLAGEN TYPE II, HUMAN
  • ANTI-COLLAGEN, TYPE II RABBIT PAB
  • ANTI-COLLAGEN TYPE II, RAT CHONDROSARCOMA
  • ANTI-COLLAGEN, TYPE II, RAT CHONDROSARCOMA (RABBIT)
  • ANTI-COLLAGEN TYPE II, MAMMALIAN
  • ANTI-HUMAN COLLAGEN, TYPE II
  • COLLAGEN TYPE II (AB-1) MONOCLONAL ANTIBODY
  • 多肽抗原
Copyright 2019 © ChemicalBook. All rights reserved